MKP11093 has shown strong results in preclinical studies with a promising safety and selectivity profile
Mangalam Drugs and Organics receives repeat export order worth $ 21, 81,040
The company has posted net profit of Rs. 1,986.43 crores for the Financial Year ended March 31, 2025
The camp, operational daily from 12 PM to 4 PM, offers free health check-ups, blood pressure monitoring
Q3 FY25 revenue up 24% to Rs 3,230 crore
Mankind Pharma will have exclusive rights to register, import, market, sell and distribute sintilimab in India
Revenue from Operations during Q2 FY25 was Rs. 3,077 crore as compared to Rs. 2,708 crore in Q2 FY24.
Potential to optimize and build on the synergies in commercial operations, distribution, manufacturing, supply chain etc.
The transaction involves the acquisition of 100% shareholding of Bharat Serums and Vaccines (BSV) by Mankind Pharma
Acquisition in line with Mankind’s stated objective to expand its presence in high entry barrier complex portfolios and high potential OTX brands
Subscribe To Our Newsletter & Stay Updated
